CHPA Appoints Dr. John P. Troup as Vice President for Scientific Affairs & Dietary Supplements

Natural Products Industry Leader Bolsters CHPA’s Expertise in Dietary Supplements
Share page:

Press Releases and Statements | Mar 9, 2020

Studio headshot of John Troup in suit and tie
John Troup

(WASHINGTON, D.C.) — The Consumer Healthcare Products Association (CHPA) today announced the appointment of Dr. John P. Troup as Vice President for Scientific Affairs & Dietary Supplements, a brand-new position within CHPA. Dr. Troup has wide-ranging experience in the health, nutrition and dietary supplements sectors, including extensive work in clinical and product development, as well as regulatory affairs. His track record boasts successful product launches and brand growth for major companies, such as Pfizer, Unilever, Novartis, and General Nutrition Centers.

In this newly created role, Dr. Troup will lead strategy development and direct CHPA’s work on dietary supplements issues, evaluating science, shaping policy, and collaborating with stakeholders for this important, growing consumer health category.

“We are thrilled to have Dr. Troup on board as our CHPA team leader for Scientific Affairs & Dietary Supplements,” said CHPA President and CEO, Scott Melville. “As CHPA adopts a more holistic approach to self-care and expands its presence in the dietary supplement category, John will play an integral role in shaping and leading our association’s dietary supplements agenda. John’s decades of experience overseeing consumer product-related initiatives and advancing research in the health, nutrition, and dietary supplements categories are a major asset to the association and its members, and we welcome him to the team.”

Most recently, Dr. Troup served as Vice President of Clinical Development, Education, and Innovation at Standard Process, Inc. As a senior R&D executive for the nutritional supplements company, he was responsible for enterprise-wide product development and innovation. Prior to this role, Dr. Troup was the Chief Science Officer at Metagenics, Inc., where he oversaw R&D and product development for a global business focused on practitioner and institutional sales of nutritional products.

“I am delighted to be joining CHPA at this pivotal point in the association’s evolution,” said Dr. Troup. “It’s an exciting time for consumer healthcare, and CHPA has positioned itself uniquely within this changing environment to better serve the needs of its members and strengthen the industry overall. I look very forward to working with this talented group of professionals.”

Founded in 1881, the Consumer Healthcare Products Association (CHPA) is the national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines, dietary supplements, and consumer medical devices. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system more than $7, contributing a total of $146 billion in savings each year. CHPA is committed to empowering consumer self-care by preserving and expanding choice and availability of consumer healthcare products.